Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: Role of Bcl-2 and caspase proteins

Archives of Virology

Volumn 149, Issue 2, 2004, Pages 289-302

  Blood, A ^a   Edwards, C J ^a   Ishii, H H ^b   Pat, B K ^a   Bryson, G ^c   Sculley, T B ^a   Gobe, G C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 3; CASPASE 9; ETOPOSIDE; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL CYCLE; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 3; CASPASE 9; CASPASES; CELL CYCLE; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 1042267629     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-003-0212-8     Document Type: Article

References (32)

1. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol 65: 1466-1478
2. Balinga BC, Kumar S (2002) Role of Bcl-2 family of proteins in malignancy. Haematol Oncol 20: 63-74
3. Barry M, McFadden G (1998) Apoptosis regulators from DNA viruses. Curr Opin Immunol 10: 422-430
4. Bozko P, Larsen AK, Raymond E, Skladanowski A (2002) Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status. Acta Biochim Pol 49: 109-119
5. Bryson GJ, Harmon BV, Collins RJ (1994) A flow cytometric study of cell death: Failure of some models to correlate with morphological assessment. Immunol Cell Biol 72: 35-41
6. Cuttle L, Zhang XJ, Endre ZH, Winterford C, Gobe GC (2001) Bcl-X(L) translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress. Kidney Int 59: 1779-1788
7. D'Souza B, Rowe M, Walls D (2000) The bfl-1 gene is transcriptionally- upregulated by the Epstein-Barr virus LMP-1, and its expression promotes the survival of a Burkitt's lymphoma cell line. J Virol 74: 6652-6658
8. Farrel PJ (1998) Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol 6: 175-178
9. Frost V, Delikat S, Al-Mehairi S, Sinclair AJ (2001) Regulation of p27KIP1 in Epstein-Barr virus-immortalised lymphoblastoid cell lines involves non-apoptotic caspase cleavage. J Gen Virol 82: 3057-3066
10. Gregory CD, Dive C, Henderson H, Smith CA, Williams GT, Gordon J, Rickinson AB (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612-614
11. Hatzivassiliou E, Mosialos G (2002) Cellular signalling pathways engaged by Epstein-Barr virus transforming protein LMP-1. Front Biosci 7: 319-329
12. Hay S, Kannourakis G (2002) A time to kill: viral manipulation of the cell death program. J Gen Virol 83: 1547-1564
13. Hennessy K, Fennewald S, Kieff E (1985) A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus. Proc Natl Acad Sci USA 82: 5944-5948
14. Ishii H, Gobé GC, Joshita T, Kurabayashi Y, Hosomura Y, Kameya T (1997) Analysis of apoptosis morphology in Epstein-Barr virus positive and negative Burkitt's lymphoma cells. Arch Histol Cytol 60: 143-152
15. Kagan VE, Tyurina YY (1999) Recycling and redox cycling of phenolic antioxidants. Ann NY Acad Sci 854: 425-434
16. Kenney JL, Guinness ME, Curiel T, Lacy J (1998) Antisense to the EBV-encoded LMP-1 suppresses LMP-1 and Bcl-2 expression and promotes apoptosis in EBV-immortalized B cells. Blood 92: 1721-1727
17. Kerr JF, Gobe GC, Winterford CM, Harmon BV (1995) Anatomical methods in cell death. Methods Cell Biol 46: 1-27
18. Knecht H, Berger C, Rothenberger S, Odermatt BF, Brousset P (2001) The role of Epstein-Barr virus in neoplastic transformation. Oncology 60: 289-302
19. Konopleva M, Zhao S, Xie Z, Segall H, Younes A, Claxton DF, Estro Z, Kornblau SM, Andreef M (1999) Apoptosis. Molecules and mechanisms. Adv Exp Med Biol 457: 217-236
20. Lyons SF, Liebowitz DN (1998) The roles of human viruses in the pathogenesis of lymphoma. Semin Oncol 25: 461-475
21. Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K, Williams L, Fingeroth J, Finberg RW (1999) Epstein-Barr virus encodes a novel homologue of the Bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol 73: 5181-5185
22. Menezes J, Leibold W, Klein G, Clements G (1975) Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22: 276-284
23. Mueller-Lantzsch N, Lenoir GM, Sauter M, Takaki K, Bechet JM, Kuklik-Roos C, Wunderlich D, Bornkamm GW (1985) Identification of the coding region for a second Epstein-Barr virus nuclear antigen (EBNA 2) by transfection of cloned DNA fragments. EMBO J 4: 1805-1811
24. Rao L, White E (1997) Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Genet Devel 7: 52-58
25. Rapoport AP, Simons-Evelyn M, Chen T, Sidell R, Luhowskyj S, Rosell K, Obrig T, Hicks D, Hinkle PM, Nahm M, Insel RA, Abboud CN (2001) Flavopiridol induces apoptosis and caspase-3 activation of a newly characterised Burkitt's lymphoma cell line containing mutant p53 genes. Blood Cells Mol Dis 27: 610-624
26. Silins S, Sculley TB (1995) Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int J Cancer 60: 65-72
27. Takada K (2001) Role of Epstein-Barr virus in Burkitt's lymphoma. Curr Top Microbiol Immunol 258: 141-151
28. Tawa R, Gao D, Takami M, Imakura Y, Lee KH, Sakurai H (1998) Binding affinity of Cu(II)-VP-16 (etoposide) complex and its analogues to DNA and hydroxyl radical generation during DNA strand breaks. Bioorg Med Chem 6: 1003-1008
29. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316
30. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T (2002) Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer 98: 498-504
31. Zinzani PL, Tani M, Molinari AL, Stefoni V, Zuffa E, Alinari L, Gabriele A, Bonifazi F, Salvucci M, Tura S, Baccarani M (2002) Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients. Haematologica 87: 816-821
32. Zhao EG, Song Q, Cross S, Misko I, Lees-Miller SP, Lavin MF (1998) Resistance to etoposide-induced apoptosis in a Burkitt's lymphoma cell line. Int J Cancer 77: 755-762